Huffman and colleagues' response to Abramson and colleagues' article on statins in low risk people.

Article English OPEN
Huffman, M ; Taylor, F ; Ebrahim, S (2014)
  • References (10)

    Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ 2013;347:f6123. (22 October.) Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;1:CD004816.

    Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol 2013; published online 7 Nov.

    Cholesterol Treatment Trialists' Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.

    Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies. the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol 2008;51:701-7.

    O'Neil A, Sanna L, Redlich C, Sanderson K, Jacka F, Williams LJ, et al. The impact of statins on psychological wellbeing: a systematic review and meta-analysis. BMC Med 2012;10:154.

    Pharmacoepidemiol Drug Saf 2007;16:627-40.

    Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006;17:2006-16.

    Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, et al. Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med 2012;9:e1001310.

    Cite this as: BMJ 2014;348:g1520 © BMJ Publishing Group Ltd 2014 Heterogeneity χ2=2.35 (degrees of freedom 1), P=0.125.

    Test of pooled relative risk 1, Z=2.32, P=0.02.

  • Metrics
    No metrics available
Share - Bookmark